Enzalutamide [Design Issues]

posted by pash413 – India, 2015-12-07 14:22 (3853 d 03:01 ago) – Posting: # 15702
Views: 6,840

Dear all
I need help to understand the dose to be administered for enzalutamide 40mg Capsule BE study.
As per recently published OGD recommendation dose is "Strength: 40 mg at a dose of 160 mg (4x40mg", however reported Cmax for for 160 mg is 3.6 µg/mL.

Can we perform study with single capsule administration for studies to be perform other than USFDA submission, because looking at the reported Cmax it will be possible to measure the concentrations with single capsule (40mg Dose).
Note; As per product lable single daily dose is 160 mg (4x 40mg)


Edit: Category changed and guidance linked. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
137 visitors (0 registered, 137 guests [including 8 identified bots]).
Forum time: 18:23 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5